COVID-19 Vaccines

March 10th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Categories:   Covid-19   Coding  
0 Votes - Sign in to vote or comment.

To accommodate the new COVID-19 immunizations the CPT editorial panel has approved 11 Category I codes. Watch for new and revised guidelines and parenthetical notes with these codes. For example; which administration codes should be used with the vaccine codes and the NCD codes applicable to the dose being administered. These codes will be effective through the duration of the Public Health Emergency. These codes were granted approval from the FDA on 12/11/20 and first appeared in the CPT codeset on 01/01/2021. 

4 New Vaccine Codes:

91300, 91301, 91302, 91303

7 New Administration codes to be used with the Vaccine codes:

0001A, 0002A, 0011A, 0012A, 0021A, 0022A, 0031A 

Vaccine Code

Description

Admin Code

MFG NDC 10/NDC 11 Prod ID (vial) Dosing
91300

SARS-CoV-2

30 mcg/0.3mL dosage

Dose #1 0001A

Dose #2  0002A 

Pfizer, Inc

Dose #1 59267-1000-1

Dose #2 59267-1000-01

21 Days
91301

SARS-CoV-2

100 mcg/0.5mL dosage

Dose #1 0011A

Dose #2 0012A

Moderna, Inc

Dose #1 80777-273-10

Dose #2 80777-0273-10

28 Days
91302

SARS-CoV-2

5x1010 viral particles/0.5mL dosage

Dose #1 0021A

Dose #2 0022A

AstraZeneca, Plc

Dose #1 0310-1222-10

Dose #2 00310-1222-10

28 Days
91303

SARS-CoV-2

 5x1010. viral particles/0.5mL dosage

1 Dose 0031A Janssen 59676-580-05 59676-0580-05 N/A

The crosswalks are intended to help entities and providers who bill for drugs understand which drug products that are identified by NDCs are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States, but are current to the best of our knowledge as of the writing of the article.

###

Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.


Latest articles:  (any category)

​​Polysomnography Services Under OIG Scrutiny
September 2nd, 2021 - Raquel Shumway
The OIG conducted a study dated June 2019 wherein they indicated that there were approximately $269 million in overpayments for polysomnography services for the period of 2014 through 2015. According to the OIG “These errors occurred because the CMS oversight of polysomnography services was insufficient to ensure that providers complied with Medicare requirements and to prevent payment of claims that didn’t meet those requirements.” So what are those requirements?
Medicare Advantage - The Fastest Growing Government-Funded Program Undergoing Multiple Fraud Investigations
August 16th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
Medicare Advantage is the fastest growing form of government-funded healthcare and the rate of fraud within this segment has come under increased scrutiny. Funding is determined by the health status of each beneficiary; therefore, accurate coding based on detailed documentation makes the medical record vital to the process because some ...
Billing Dental Implants under Medical Coverage
August 12th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Implants can be costly to the patient and the provider, and it is crucial to understand how to bill a patient’s medical insurance to ensure there is adequate coverage for the best treatment. Implants are commonly billed in a dental office under a patient’s medical benefits.    Implants could be considered ...
New Codes for COVID Booster Vaccine & Monoclonal Antibody Products
August 10th, 2021 - Wyn Staheli, Director of Research
New codes have been announced for the COVID-19 booster vaccine, Novavax vaccine, and monoclonal antibody treatment.
Medicare's ABN Booklet Revised
July 29th, 2021 - Wyn Staheli, Director of Research
The “Medicare Advance Written Notices of Non-coverage” booklet, published by CMS’s Medicare Learning Network, was updated. This article discusses the changes to this booklet regarding the use of the ABN.
Chronic Pain Coding Today & in the Future
July 19th, 2021 - Wyn Staheli, Director of Research
Properly documenting and coding chronic pain can be challenging. As is commonly the case with many conditions, over the years, there has been a shift in the identification of different types of pain, including chronic pain. Understanding where we are now and where we are going will help your organization prepare for the future by changing documentation patterns now.
How Does Global and Professional Direct Contracting (GPDC) Affect Risk Adjustment?
July 15th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
CMS recently announced the 53 Direct Contracting Entities (DCEs) that will be participating in the April 1, 2021 through December 31, 2021 Global and Professional Direct Contracting (GPDC) Model. Among those participating is Clover Health Partners, who runs an in-home primary care program that has the potential to help Medicare ...



Home About Contact Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2021 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association